Skip to content

The effect of 3% Diquafosol Sodium ophthalmic solution for High-order aberration on the patient diagnosed as the dry eye after a cataract surgery.

The effect of 3% Diquafosol Sodium ophthalmic solution for High-order aberration on the patient diagnosed as the dry eye after a cataract surgery. - The effect of 3% Diquafosol Sodium ophthalmic solution for High-order aberration on the patient diagnosed as the dry eye after a cataract surgery.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000022332
Enrollment
105
Registered
2016-06-01
Start date
2016-05-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye

Interventions

None listed

Sponsors

Inoue Eye Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Implemented an age-related cataract surgery. - Patients who are diagnosed as definite or probable dry eye by Dry Eye Diagnostic Criteria (study eye) before apply. - The Corneal and conjunctival staining was more than 1 point (out of 9 points) before apply.

Exclusion criteria

Exclusion criteria: - Patients who have allergic conjunctivitis and have possibilities to get worse during study phase. - Patients who have glaucoma and uveitis requiring treatment. - Histories of Lasik, blepharoplasty,ocular injury or corneal transplants. - Patients had a naked eye surgery of ocular trauma within 1 year before this study. - Patients who have diabetic retinopathy. - History of allogeneic hematopoietic stem cell transplantation. - Patients who had a punctual plug. - Used a prohibited concurrent drug. - Received prohibited concurrent therapy. - Wore contact lenses. - The investigator/subinvestigator has judged that the patient is ineligible as a subject of the study.

Design outcomes

Primary

MeasureTime frame
-High-order aberration -Tear film breakup time(BUT) -Corneal and conjunctival staining score -Subjective symptoms (12 items) -Adverse event and side effect

Countries

Japan

Contacts

Public ContactYasushi Inoue

Inoue Eye Clinic No

inoue@oka.urban.ne.jp0863-31-1030

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026